Liang, L.; He, H.; Jiang, S.; Liu, Y.; Huang, J.; Sun, X.; Li, Y.; Jiang, Y.; Cong, L.
TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. Int. J. Mol. Sci. 2022, 23, 10415.
https://doi.org/10.3390/ijms231810415
AMA Style
Liang L, He H, Jiang S, Liu Y, Huang J, Sun X, Li Y, Jiang Y, Cong L.
TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. International Journal of Molecular Sciences. 2022; 23(18):10415.
https://doi.org/10.3390/ijms231810415
Chicago/Turabian Style
Liang, Lu, Hua He, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, and Li Cong.
2022. "TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma" International Journal of Molecular Sciences 23, no. 18: 10415.
https://doi.org/10.3390/ijms231810415
APA Style
Liang, L., He, H., Jiang, S., Liu, Y., Huang, J., Sun, X., Li, Y., Jiang, Y., & Cong, L.
(2022). TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. International Journal of Molecular Sciences, 23(18), 10415.
https://doi.org/10.3390/ijms231810415